Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00319826 · ClinicalTrials.gov registry record
Virulence Determinants in S Aureus Bacteremia
A clinical trial of Bacteremia, sponsored by Duke University.
- Completed
- Registry status
- 1,354
- Enrollment target
- 1
- Study location
NCT00319826: Completed study of Bacteremia, sponsored by Duke University.
NCT00319826 is a study of Bacteremia that has completed, run by Duke University. The registered enrollment target is 1,354 participants, below the 7,454-participant average among 11 other Bacteremia trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00319826, a study of Bacteremia, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 1,354 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate why some people develop life-threatening infections caused by the bacteria Staphylococcus aureus, while other people do not. It is possible that the infectious ability of the bacteria can determine whether an infection develops and its severity. The investigators will look at old blood and nasal specimens collected from 1000 adults who had S. aureus infections and who were hospitalized at Duke University Medical Center. Previously collected health information regarding these patients and the specific bacterial traits in the samples will be studied. Eventually this information may be used to help treat and prevent S. aureus infection.
Conditions Studied
Interventions
- OTHER No intervention
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,354 participants |
| Start Date | 2004-03 |
| Est. Completion | 2013-08 |
What the finished NCT00319826 record still lists
NCT00319826 is an observational study that tracks outcomes without assigning an intervention. Its 1,354 participants enrollment target places it among the larger protocols in the corpus, below the 7,454-participant average among 11 other Bacteremia trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Bacteremia appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.
NCT00319826 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT00319826 about?
NCT00319826 is a clinical study titled "Virulence Determinants in S Aureus Bacteremia". The purpose of this study is to investigate why some people develop life-threatening infections caused by the bacteria Staphylococcus aureus, while other people do not. It is possible that the infectious ability of the bacteria can determine whether an infection develops and its severity. The invest...
What is the current status of trial NCT00319826?
This trial is currently completed. The enrollment target is 1,354 participants. The study started on 2004-03. Estimated completion is 2013-08.
What conditions does trial NCT00319826 study?
This clinical trial studies the following conditions: Bacteremia.
What interventions are being tested in trial NCT00319826?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT00319826?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00319826 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bacteremia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00319826's enrollment target sits among peer trials
1,354 6th of 11 higher than 6 of 11 other Bacteremia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bacteremia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reducing Risk for Infective Endocarditis
RECRUITING · NA
-
Evaluation of Emergency Medicine Pharmacist Impact on Blood Culture Review Following Emergency Department Discharge
RECRUITING
-
Monocyte Distribution Width (MDW) in the General Population of Emergency Department Patients With and Without Bacteremia
ACTIVE NOT RECRUITING
-
Antibiotic Administration and Blood Culture Positivity in Severe Sepsis and Septic Shock
COMPLETED
-
Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness
COMPLETED · NA
-
Multicenter Blood Culture Quality Improvement
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05245227 · 1,358 participants · Phase 3
Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage
- NCT06318169 · 1,350 participants · Phase 3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- NCT06605404 · 1,350 participants
Pan-tumor MRD Study
- NCT06806163 · 1,350 participants · NA
Machine-Learning Prediction and Reducing Overdoses With EHR Nudges
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia